Impact of age at onset and newborn screening on outcome in organic acidurias

[1]  K. Hornik,et al.  A Laboratory for Recursive Partytioning , 2015 .

[2]  E. Jameson,et al.  Optic neuropathy in methylmalonic acidemia and propionic acidemia , 2015, British Journal of Ophthalmology.

[3]  S. Kölker,et al.  Newborn Screening for Glutaric Aciduria Type I: Benefits and limitations , 2015 .

[4]  M. Baumgartner,et al.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation , 2015, Journal of Inherited Metabolic Disease.

[5]  M. Baumgartner,et al.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype , 2015, Journal of Inherited Metabolic Disease.

[6]  Anita MacDonald,et al.  Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia , 2014, Orphanet Journal of Rare Diseases.

[7]  A. Ribes,et al.  Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models—a cohort study in 180 patients , 2014, Journal of Inherited Metabolic Disease.

[8]  S. Listl,et al.  Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis , 2013, Orphanet Journal of Rare Diseases.

[9]  N. Boddaert,et al.  Long-term neurological outcome of a cohort of 80 patients with classical organic acidurias , 2013, Orphanet Journal of Rare Diseases.

[10]  H. Mandel,et al.  Subependymal mass lesions and peripheral polyneuropathy in adult-onset glutaric aciduria type I , 2013, Neurology.

[11]  M. Baumgartner,et al.  Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients , 2013, Orphanet Journal of Rare Diseases.

[12]  C. Greenberg,et al.  Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience. , 2012, Molecular genetics and metabolism.

[13]  N. Longo,et al.  Glutaric acidemia type 1: outcomes before and after expanded newborn screening. , 2012, Molecular genetics and metabolism.

[14]  Luciano Vittozzi,et al.  Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1 - From blood spot to screening result , 2012, Journal of Inherited Metabolic Disease.

[15]  A. Macdonald,et al.  Feeding difficulties in children with inherited metabolic disorders: a pilot study. , 2012, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[16]  M. Leichsenring,et al.  Clinical and neurocognitive outcome in symptomatic isovaleric acidemia , 2012, Orphanet Journal of Rare Diseases.

[17]  M. Baumgartner,et al.  Propionic acidemia: neonatal versus selective metabolic screening , 2012, Journal of Inherited Metabolic Disease.

[18]  N. Leslie,et al.  Cardiac disease in methylmalonic acidemia. , 2011, The Journal of pediatrics.

[19]  A. Moser,et al.  Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx. , 2011, Molecular genetics and metabolism.

[20]  M. Durán,et al.  Diagnosis and management of glutaric aciduria type I – revised recommendations , 2011, Journal of Inherited Metabolic Disease.

[21]  E. Mayatepek,et al.  Chronic pancreatitis in branched-chain organic acidurias—a case of methylmalonic aciduria and an overview of the literature , 2011, European Journal of Pediatrics.

[22]  I. Harting,et al.  Use of guidelines improves the neurological outcome in glutaric aciduria type I , 2010, Annals of neurology.

[23]  B. Wilcken.  Expanded newborn screening: reducing harm, assessing benefit , 2010, Journal of Inherited Metabolic Disease.

[24]  M. Baumgartner,et al.  Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters , 2009, Journal of Inherited Metabolic Disease.

[25]  J. Christodoulou,et al.  Glutaric aciduria type I: outcome following detection by newborn screening , 2008, Journal of Inherited Metabolic Disease.

[26]  A. Boneh,et al.  Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. , 2008, Molecular genetics and metabolism.

[27]  James Allan,et al.  A comparison of statistical significance tests for information retrieval evaluation , 2007, CIKM '07.

[28]  Melinda H. McCann,et al.  Multiple Comparison of Medians Using Permutation Tests , 2007 .

[29]  J. Zschocke,et al.  Decline of Acute Encephalopathic Crises in Children with Glutaryl-CoA Dehydrogenase Deficiency Identified by Newborn Screening in Germany , 2007, Pediatric Research.

[30]  M. Baumgartner,et al.  Long-Term Outcome in Methylmalonic Acidurias Is Influenced by the Underlying Defect (mut0, mut−, cblA, cblB) , 2007, Pediatric Research.

[31]  M. Wintermark,et al.  Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. , 2007, Brain : a journal of neurology.

[32]  K. Hornik,et al.  Unbiased Recursive Partitioning: A Conditional Inference Framework , 2006 .

[33]  A. Ribes,et al.  Natural History, Outcome, and Treatment Efficacy in Children and Adults with Glutaryl-CoA Dehydrogenase Deficiency , 2006, Pediatric Research.

[34]  C. Dionisi-Vici,et al.  ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long-term outcome and effects of expanded newborn screening using tandem mass spectrometry , 2006, Journal of Inherited Metabolic Disease.

[35]  S. Cederbaum,et al.  Clinical, pathological, and biochemical studies in a patient with propionic acidemia and fatal cardiomyopathy. , 2005, Molecular genetics and metabolism.

[36]  D. Rabier,et al.  Methylmalonic and propionic acidaemias: Management and outcome , 2005, Journal of Inherited Metabolic Disease.

[37]  S. Edland,et al.  A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. , 2004, American journal of human genetics.

[38]  M. Schemper,et al.  A solution to the problem of separation in logistic regression , 2002, Statistics in medicine.

[39]  R. Surtees,et al.  Neurological outcome of methylmalonic acidaemia , 1998, Archives of disease in childhood.

[40]  M. Baumgartner,et al.  Networking Across Borders for Individuals with Organic Acidurias and Urea Cycle Disorders: The E-IMD Consortium. , 2015, JIMD reports.

[41]  V. Sutton,et al.  Chronic management and health supervision of individuals with propionic acidemia. , 2012, Molecular genetics and metabolism.

[42]  V. Sutton,et al.  Neurologic considerations in propionic acidemia. , 2012, Molecular genetics and metabolism.

[43]  V. Sutton,et al.  Natural history of propionic acidemia. , 2012, Molecular genetics and metabolism.

[44]  D. Rabier,et al.  Cardiomyopathies in propionic aciduria are reversible after liver transplantation. , 2010, The Journal of pediatrics.